PharmiWeb.com - Global Pharma News & Resources
30-May-2023

Medication Management System Market is anticipated to garner US$ 7.1 Billion by 2032 | FMI Study

[300 Pages Report] The global medication management system industry is gaining momentum as lack of enough pharmacists and healthcare professionals is necessitating the requirement for an efficient management system to ensure the workflow. While the pandemic has brought substantial changes in the medical and healthcare industry due to shifted demand-supply patterns, the need to curtail medical errors grew stronger resulting in prominent demand for medication management systems.

The latest revised edition of the report on the ‘medication management system’ market study by Future Market Insights (FMI) offers detailed insights of the global industry, growth & restraining factors, and demand-supply trajectories across 20+ countries during the forecast period of 2021 to 2031. According to the report, the industry players will thrive on the rising number of machines and inventory management equipment in the hospitals and healthcare sectors while eyeing the main regions such as North America, Europe, and Asia Pacific, to name a few.

Request a report sample to gain comprehensive insights at https://www.futuremarketinsights.com/reports/sample/rep-gb-1419

Key Takeaways from Market Study

  • The global medication management system industry to ascend at over 15% CAGR through 2031
  • High requirement for computerized physician order entry and inventory management solutions is likely to be witnessed
  • Growing requirement from hospitals and pharmacies to favor manufacturers
  • On-premise and web-based solutions to gain traction in terms of mode of delivery
  • The United States to remain the epicenter of the world’s largest medication management system industry North America
  • Germany to remain dominant in the Europe medication management system industry
  • Asia-Pacific to exhibit the fastest growth during the forecast period
  • China, Japan, India, the United Kingdom, France, Italy, and a few other countries to remain lucrative for stakeholders

“With the medical and healthcare industries adopting cutting-edge technical solutions in order to efficiently manage medication and inventory, demand for medication management system is sky-rocketing. Furthermore, rising inclination towards cloud-based solutions is set to raise the revenue for suppliers and manufacturers in the foreseeable future,” says an FMI analyst.

How is the Increase in Demand from Hospitals Industry Fuelling Sales of Medication Management System Suppliers?

Medication management systems are being deployed extensively by healthcare professionals in order to efficiently manage various information such as patient analysis, regulatory & compliance information, valuation analysis and other vital parameters in healthcare industry.

According to the report titled “Industries at a Glance: Hospitals” published by the Bureau of Labor Statistics, the United States hospitals industry is highly potential and progressive and comprises of medical, diagnostic, treatment, and other inpatient and outpatient services which include physician, nursing, and other health services. As stated in the report, the employment in this sector has decreased to 5,135.1 in thousands in February, 2021, compared to 5,136.3 in thousands in November, 2020. These data give a glimpse of the upcoming opportunities for medication management system providers around the globe.

Who is Winning in this Space?

With the competition getting stricter, key players in the global medication management system market are diversifying their products in order to target broader end-use sectors.

For instance,

  • Omnicell, Inc. lunched its new extensive range of products such as i.v.STATION Non-hazardous Compounding Robot, IVX Workflow, AccuFlex, MTS-350 Filler and Sealer, and others during the last 5 years
  • Cerner Corporation launched its new Automated Dispensing Cabinet, Drug Database Solutions, and others a couple of years back

More Valuable Insights

In its latest report, FMI offers an unbiased analysis of the medication management system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of software type (computerized physician order entry, clinical decision support system solutions, electronic medication administration record, inventory management solutions, and other software types), end use (hospitals, pharmacies, and other healthcare institutions), and mode of delivery (on-premise solutions, web-based solutions, and cloud-based solutions), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Are you looking for customized information related to the latest trends, drivers, and challenges? Speak to Our Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-1419

Medication Management System Segmentation by Category Software Type

  • Computerized Physician Order Entry
  • Clinical Decision Support System Solutions
  • Electronic Medication Administration Record
  • Inventory Management Solutions
  • Other Software Types

End Use

  • Hospitals
  • Pharmacies
  • Other Healthcare Institutions

Mode of Delivery

  • On-Premise Solutions
  • Web-Based Solutions
  • Cloud-Based Solutions

Have a Look at Related Research Reports in the Healthcare Domain:

Esophageal Implant Market Trend: The global esophageal implant market size is estimated to reach US$ 147.0 million in 2023. From 2023 to 2033, global esophageal implant sales are projected to soar at 6.7% CAGR. By the end of 2033, total market value is likely to exceed US$ 280.2 million.

Mastectomy Reconstruction Implants Market ForecastAccording to Future Market Insights (FMI) analysis in a recent market survey, the global mastectomy reconstruction implants market was valued at US$ 1.95 Billion in 2022 and is set to reach US$ 4.69 Billion by 2033.

Fecal Pancreatic Elastase Testing Market Sales: The fecal pancreatic elastase testing market is expected to increase from US$ 15,306.7 million in 2023 to US$ 31,842.3 million by 2033. The market is likely to capture a 7.6% CAGR from 2023 to 2033.

About FMI:

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact Us:
Future Market Insights,
Unit No: 1602-006, Jumeirah Bay 2, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
LinkedIn| Twitter| Blogs
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com

Editor Details

Last Updated: 30-May-2023